Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Epidermal growth factor receptor transactivation mediates tumor necrosis factor-induced hepatocyte replication.

Authors: Argast, Gretchen M; Campbell, Jean S; Brooling, John T; Fausto, Nelson

Published In J Biol Chem, (2004 Aug 13)

Abstract: Tumor necrosis factor (TNF) has multiple biological effects such as participating in inflammation, apoptosis, and cell proliferation, but the mechanisms of its effects on epithelial cell proliferation have not been examined in detail. At the early stages of liver regeneration, TNF functions as a priming agent for hepatocyte replication and increases the sensitivity of hepatocytes to growth factors such as transforming growth factor alpha (TGFalpha); however, the mechanisms by which TNF interacts with growth factors and enhances hepatocyte replication are not known. Using the AML-12 hepatocyte cell line, we show that TNF stimulates proliferation of these cells through transactivation of the epidermal growth factor receptor (EGFR). The transactivation mechanism involves the release of TGFalpha into the medium through activation of the metalloproteinase TNFalpha-converting enzyme (also known as ADAM 17). Binding of the ligand to EGFR initiates a mitogenic cascade through extracellular signal-regulated kinases 1 and 2 and the partial involvement of protein kinase B. TNF-induced release of TGFalpha and activation of EGFR signaling were inhibited by TNFalpha protease inhibitor-1, an agent that interferes with TNFalpha-converting enzyme activity. We suggest that TNF-induced transactivation of EGFR may provide an early signal for the entry of hepatocytes into the cell cycle and may integrate proliferative and survival pathways at the start of liver regeneration.

PubMed ID: 15199050 Exiting the NIEHS site

MeSH Terms: ADAM Proteins; ADAM17 Protein; Animals; Blotting, Western; Bromodeoxyuridine/pharmacology; Buffers; Cell Division; Cell Line; Cell Membrane/metabolism; Cells, Cultured; Coloring Agents/pharmacology; Culture Media, Serum-Free/metabolism; DNA/metabolism; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Epithelial Cells/metabolism; ErbB Receptors/metabolism*; Hepatocytes/metabolism*; Humans; Ligands; Liver/physiology; Metalloendopeptidases/metabolism; Mice; Mitogen-Activated Protein Kinase 1/metabolism; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases/metabolism; Mitogen-Activated Protein Kinases/metabolism; Phosphatidylinositol 3-Kinases/metabolism; Phosphorylation; Precipitin Tests; Protein-Serine-Threonine Kinases/metabolism; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins/metabolism; Regeneration; Signal Transduction; Thymidine/metabolism; Time Factors; Transcriptional Activation*; Tumor Necrosis Factor-alpha/metabolism

to Top